https://charts.traderzeitung.de/phases/US42328V8761 string(1459) "{"isin":"US42328V8761","name":"Solana Co","stock_id_xnas":132475539,"stock_id_xnys":132475540,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":2.77,"close_at":"2026-09-21 13:39:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.13,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":12.9964},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.13,"close_at":"2026-09-21 23:38:00","complete":true,"perf_pct":0}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.25,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":3.8339},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.25,"close_at":"2026-09-22 23:58:00","complete":true,"perf_pct":0}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.36,"close_at":"2026-09-23 13:38:00","complete":true,"perf_pct":3.3846},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.87,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-14.5833},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Solana Aktie News & Nachrichten

[WKN: A41AV3 | Symbol: HSDT]

Realtimekurs

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Solana gefunden werden.

Solana Nachrichtenticker öffnen

MT Newswires 22.09.2026 14:02 Uhr

Solana Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

Research-Alert: B. Riley erhöht Kursziel für Solana von 3,50 $ auf 4 $, belässt Rating auf Buy

--B. Riley passt Kursziel für Helius Medical Technologies von $2,50 auf $3,50 an, Rating bleibt bei Buy

--B. Riley senkt das Kursziel für Solana von 3 $ auf 2,50 $, behält Buy-Rating bei

Solana verringert Verlust im Q2, Umsatz steigt

Solana geht Blockchain-Partnerschaft mit Kasachstans Alatau City ein

Solana Company lehnt unerbetenes Übernahmeangebot von Forward Industries ab

Forward Industries drängt Solana bezüglich der Entscheidung, eine reine Aktien-Unternehmenszusammenführung abzulehnen

Forward Industries unterbreitet Übernahmeangebot für Solana, SkyAI; Solana lehnt ab, keine Antwort von SkyAI